Irish patients excluded from drug trials for life-saving treatments due to barriers
Ireland attracting fewer clinical trials than some European countries
Vaccine activists accuse Big Pharma of relying on public money
Waiving patent rights may have chilling effect on medicine development, industry warns
Covid-19: Vaccine industry and activists at odds over Trips waiver
Industry says waiver of IP rights not needed as vaccine supply far outweighs demand
Ireland slow to approve cancer medicines for patient use
Just half of 41 cancer drugs approved from 2017-2020 were available here at end of 2021
Medicine costs could become unsustainable, report warns
Spending review says that confidential pricing deals make it more difficult for HSE to contain drug costs
State slower to ‘adopt new drugs’ than most of western Europe
Medicines regularly not worth approving at asking price
Ireland an outlier without access to new cell and gene therapy, report says
Upfront costs high but treatments may cut long-term expense and boost patient results
Irish arm of pharma giant Roche ‘trading profitably’ despite Covid-19
Company recorded 80 per cent increase in pretax profit to €8.59 million in 2019
Report highlights new medicines’ huge economic benefits to State
New medicines have cut number of years of life lost to heart disease by 34% since 2005
Covid bounce returns RTÉ to profit for first time in three years
Seen and Heard: construction lockdown slammed, Davy review to look at deals before Anglo
State releases €30m to supply new medicines
Deal with pharma sector comes as talks on new drug pricing deal deferred until May
EU faces global criticism over vaccine export restrictions
Canada, Japan and South Korea warn against grab for vaccine supplies
Three-quarters of people in Republic will take Covid vaccine, survey says
Study finds high proportion of people willing to get immunised against coronavirus
A lot on the table as Big Pharma prepares to sit down with State over medicines
State’s lack of a clear budget structure for medicines is a frustration for Big Pharma
Ireland is a world leader in producing cancer therapies but we lag behind on access
Budget 2021 is a chance to address our poor performance in bringing medicines we make to our patients
Pharma lobby group appoints Paul Reid as president
Irish Pharmaceutical Healthcare Association seeks State accord on access to new therapies
Medicines pricing agreement extended for six months
Government and pharma companies agree space for discussions on longer-term pricing
Pharma body hopeful of extending deal with State on cost of medicines
Current agreement due to expire at the end of July after savings of about €600m
Pharmaceutical industry signals it won’t extend drugs agreement
Four-year-old accord on supply and pricing of medicines is set to expire at end of July
Irish pharma sector warns of protectionism as US corners supply
Alert comes after US secures Covid-19 drug treatment for next three months
Calls for new government to give faster access to life-saving drugs
Pharma group says eight cancer therapies awaiting HSE approval for over 900 days
Three in four Irish willing to test new treatments if ill
Almost half surveyed say cancer is the disease science has greatest potential to cure
Patients wait longer for new medicines in Ireland than in Europe – Ipha
Industry study tracks 15 drugs that have yet to be approved by the HSE for use in Irish hospitals
‘We’re not even using the UK as a landbridge’
Ger Brennan, who runs the Irish operation of MSD, is Brexit-ready and focusing on other issues
HSE not approving new drugs that generate additional costs
Donohoe told Harris in August he wanted ban on new medicines for remainder of year
Taking Takeda global with new Irish pharma plant centre stage
Christophe Weber has overseen the $62 billion takeover of Shire and the opening of a new plant in Dublin
Pharma lobby presses case for funding new medicines
PwC report on European drug sector highlights contributions to economy and society
Pricing of medicines needs to be reformed, says IPHA president
Aidan Lyncht HSE should not be expected to pay for drugs that are not innovative
Website detailing funding to doctors back online after investigation
Pharmaceutical industry body suspected site may have been ‘compromised’
Ireland compares poorly with Europe for access to medicines - report
Study examines access to 121 drugs approved since 2015 by EU regulator
Ten new medicines waited more than two years for HSE approval
Medicines generally blocked on basis of price as Ipha says delay ‘unacceptably long’
Most new drugs for treating rare diseases not approved for sale in Ireland
Pharma body says less than one-third of medicines for rare diseases licensed for patients in Europe are available in the Republic
Drug companies angry at allegation of ‘predatory pricing’
Row between industry and body that advises the HSE over access to market for new medicines
The Irish Times view on health services: allaying public concern
With an overall percentage drop in this year’s HSE budget, primary care’s minuscule share of health spend will continue
Emergency medicines to be fast-tracked into State after Brexit
Revenue makes plans to avoid disruption to supplies after UK’s exit from the EU
Call on Harris to focus on supply of medicines after Brexit
Companies say they are working actively to prepare for worst-case Brexit scenario
Big Pharma bids to build bridges in Ireland
Irish industry’s chief looks for partnership as he admits trust is lacking
Budget 2019: ‘It does nothing to address the crisis out there’
Housing, health, property and environmental groups react to the budget
Call for fresh approach to funding new medicines
Pharmaceutical sector urges faster access to markets and sharper focus on innovation
Irish patients denied access to drugs made in Ireland
Pharma companies says drugs being exported to European markets but are not approved here
Big Pharma scathing on failure to endorse new cancer medicines
Cancer strategy targets ‘to be missed’ if new generation drugs not backed by Government
Ireland’s IP image may be hit by drug patent waiver, pharma body warns
Lobby group says fewer medicines will come to market if EU alters patent right protection
Moves on IP rights in Europe could affect jobs in Ireland, drug firms warn
EU states expected to discuss plans to loosen restrictions on manufacturing by generics firms
Pharma body calls for more State funding on medicines
Government to save €15m this year as prices fall across 750 drugs
Ireland urgently needs access to new drugs, says pharma body
Simon Harris signs agreement to make innovative medicines available to Irish patients
EU proposes waiver for manufacturers of generic drugs
Big pharma companies object to change that would allow generic manufacture of protected medicines for markets outside the bloc
Up to 25,000 pharma jobs if EU alters patent rules
Mylan boss calls for waiver on manufacturing of biosimilars
Former government adviser joins pharma lobby group
Bernard Mallee appointed as IPHA’s director of communications and advocacy
Price pressure keeps nine new drugs from Irish patients
Cancer drugs feature in list of therapies waiting HSE approval on cost grounds
Roche says drug pricing agreement is hurting profits at its Irish unit
Pharma giant pays €5 million dividend to parent as revenues rise to €109 million
Irish patients waiting longer for new drugs, say pharma firms
Simon Harris tells pharma firms they must reassess price models and profit expectations
Government’s hospital pass to HSE on approval for new medicines
Approval has been handed back to the HSE but without any more money for drugs
Government puts new drug approvals back in HSE’s hands
Move seen as a way for Department of Health to distance itself from rows over drug funding
Big Pharma and HSE need to take a chill pill over drug prices
The framework agreement signed a year ago has not brought the two sides together
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices